Validate genomic variants causing human birth defects to bridge the gap from identification to functional impact using genetic data and in-silico tools.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing)
Funding Amounts: Up to $499,999 in direct costs per year for up to 5 years; no cost sharing required.
Summary: Supports screening, functional validation, and mechanistic characterization of human genomic variants associated with congenital anomalies.
Key Information: Animal-model validation is required; exclusively in vitro studies and clinical trials are not allowed.
This NIH R01 program supports research connecting congenital anomaly-associated genomic variants to their functional effects. Participating components are the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Dental and Craniofacial Research (NIDCR), and Office of Research Infrastructure Programs (ORIP). The goal is to translate functional genomic knowledge into strategies for molecular diagnosis, treatment, and prevention of human birth defects.
Projects may use non-hypothesis-driven screening, hypothesis-driven mechanistic studies, or both. Variants may come from public databases or individual and group efforts, including ClinGen Expert Curation Panels. Coding and noncoding variants, single-base substitutions, copy-number changes, and chromosomal rearrangements are within scope. Supported approaches combine computational prioritization, cell-based assays, and appropriate animal models to establish how variants affect developmental processes and disease phenotypes.